ISRG · Earnings call · 2026Q3T · Full report

Strategic Cost Reduction

INTUITIVE SURGICAL INC · 2026-10-20 · Importance 34 · Surprise 42

Intuitive plans to begin implementing instrument pricing actions in the first half of 2027, including extending the useful lives of a subset of core EndoWrist instruments on fourth- and fifth-generation platforms and introducing volume-based pricing. The actions target high-volume benign procedures where cost can constrain broader access, and are intended to lower customer cost per procedure. Once fully implemented, the pricing actions together with the China price reduction are expected to lower da Vinci I&A revenue per procedure by approximately 3%–5% on a mix-constant basis; rollout will proceed country by country through 2027.